Works by Muroi, Nobuyuki

Results: 27

Adverse Event Profile of Azacitidine: Analysis by Route of Administration Using Japanese Pharmacovigilance Database.

Published in:

Oncology, 2023, v. 101, n. 10, p. 664, doi. 10.1159/000531390

By:

Yamaoka, Kenta;
Fujiwara, Masaki;
Uchida, Mayako;
Uesawa, Yoshihiro;
Muroi, Nobuyuki;
Shimizu, Tadashi

Publication type:

Article

Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database.

Published in:

Oncology, 2022, v. 100, n. 7, p. 413, doi. 10.1159/000524806

By:

Yamaoka, Kenta;
Fujiwara, Masaki;
Uchida, Mayako;
Uesawa, Yoshihiro;
Muroi, Nobuyuki;
Shimizu, Tadashi

Publication type:

Article

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis.

Published in:

Supportive Care in Cancer, 2022, v. 30, n. 3, p. 2341, doi. 10.1007/s00520-021-06634-7

By:

Ikesue, Hiroaki;
Doi, Kohei;
Morimoto, Mayu;
Hirabatake, Masaki;
Muroi, Nobuyuki;
Yamamoto, Shinsuke;
Takenobu, Toshihiko;
Hashida, Tohru

Publication type:

Article

Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.

Published in:

Supportive Care in Cancer, 2021, v. 29, n. 8, p. 4763, doi. 10.1007/s00520-021-06018-x

By:

Ikesue, Hiroaki;
Mouri, Moe;
Tomita, Hideaki;
Hirabatake, Masaki;
Ikemura, Mai;
Muroi, Nobuyuki;
Yamamoto, Shinsuke;
Takenobu, Toshihiko;
Tomii, Keisuke;
Kawakita, Mutsushi;
Katoh, Hironori;
Ishikawa, Takayuki;
Yasui, Hisateru;
Hashida, Tohru

Publication type:

Article

Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib.

Published in:

Cancer Chemotherapy & Pharmacology, 2022, v. 89, n. 6, p. 833, doi. 10.1007/s00280-022-04408-4

By:

Ikesue, Hiroaki;
Yamaoka, Kenta;
Matsumoto, Ayako;
Hirabatake, Masaki;
Muroi, Nobuyuki;
Yamasaki, Toshinari;
Kawakita, Mutsushi;
Hashida, Tohru

Publication type:

Article

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.

Published in:

2021

By:

Ikesue, Hiroaki;
Doi, Kohei;
Morimoto, Mayu;
Hirabatake, Masaki;
Muroi, Nobuyuki;
Yamamoto, Shinsuke;
Takenobu, Toshihiko;
Hashida, Tohru

Publication type:

journal article

Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 659, doi. 10.1007/s40801-022-00324-4

By:

Hasegawa, Shiori;
Ikesue, Hiroaki;
Satake, Riko;
Inoue, Misaki;
Yoshida, Yu;
Tanaka, Mizuki;
Matsumoto, Kiyoka;
Wakabayashi, Wataru;
Oura, Keita;
Muroi, Nobuyuki;
Hashida, Tohru;
Iguchi, Kazuhiro;
Nakamura, Mitsuhiro

Publication type:

Article

Comprehensive Analysis of Adverse Events Induced by PARP Inhibitors Using JADER and Time to Onset.

Published in:

Life (2075-1729), 2022, v. 12, n. 9, p. 1355, doi. 10.3390/life12091355

By:

Yamaoka, Kenta;
Fujiwara, Masaki;
Uchida, Mayako;
Uesawa, Yoshihiro;
Muroi, Nobuyuki;
Shimizu, Tadashi

Publication type:

Article

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.529654

By:

Satsuma, Yukari;
Ikesue, Hiroaki;
Kusuda, Kaori;
Maeda, Mami;
Muroi, Nobuyuki;
Mori, Ryobu;
Kogo, Mariko;
Hirabayashi, Ryosuke;
Nagata, Kazuma;
Nakagawa, Atsushi;
Tachikawa, Ryo;
Tomii, Keisuke;
Hashida, Tohru

Publication type:

Article

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.901099

By:

Hirabatake, Masaki;
Ikesue, Hiroaki;
Iwama, Yuna;
Irie, Kei;
Yoshino, Shintaro;
Yamasaki, Toshinari;
Hashida, Tohru;
Kawakita, Mutsushi;
Muroi, Nobuyuki

Publication type:

Article

Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma.

Published in:

Investigational New Drugs, 2023, v. 41, n. 5, p. 761, doi. 10.1007/s10637-023-01392-1

By:

Yamaoka, Kenta;
Irie, Kei;
Hiramoto, Nobuhiro;
Hirabatake, Masaki;
Ikesue, Hiroaki;
Hashida, Tohru;
Shimizu, Tadashi;
Ishikawa, Takayuki;
Muroi, Nobuyuki

Publication type:

Article

Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database.

Published in:

In Vivo, 2025, v. 39, n. 1, p. 396, doi. 10.21873/invivo.13841

By:

MASAKI FUJIWARA;
HIROAKI IKESUE;
KENTA YAMAOKA;
MAYAKO UCHIDA;
YOSHIHIRO UESAWA;
NOBUYUKI MUROI;
TADASHI SHIMIZU

Publication type:

Article

Factors Associated With Mortality in Patients With Catheter-related Bloodstream Infection: A Multicenter Retrospective Study.

Published in:

In Vivo, 2024, v. 38, n. 6, p. 3041, doi. 10.21873/invivo.13788

By:

AKIHIKO FUTAMURA;
TAKENAO KOSEKI;
TSUYOSHI NAKAI;
NOBUYUKI MUROI;
MICHIAKI MYOTOKU;
JUNICHI IIDA;
HIROKI MAKI;
AKITO SUZUKI;
KAZUHISA MIZUTANI;
HIKARU OGINO;
YASUKI TANIGUCHI;
KEIICHIRO HIGASHI;
MASANOBU USUI

Publication type:

Article

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19.

Published in:

CTS: Clinical & Translational Science, 2020, v. 13, n. 5, p. 880, doi. 10.1111/cts.12827

By:

Irie, Kei;
Nakagawa, Atsushi;
Fujita, Hirotoshi;
Tamura, Ryo;
Eto, Masaaki;
Ikesue, Hiroaki;
Muroi, Nobuyuki;
Tomii, Keisuke;
Hashida, Tohru

Publication type:

Article

Regulation of Histamine Turnover via Muscarinic and Nicotinic Receptors in the Brain.

Published in:

Journal of Neurochemistry, 1990, v. 55, n. 6, p. 1899, doi. 10.1111/j.1471-4159.1990.tb05774.x

By:

Oishi, Ryozo;
Adachi, Naoto;
Okada, Keishi;
Muroi, Nobuyuki;
Saeki, Kiyomi

Publication type:

Article

Efficiently Reducing Medical Costs through Drug Vial Optimization and Multidose Vials for the Utilization of Cancer Drug Compounding Robots: Efficiently Reducing Medical Costs through Cancer Drug Compounding Robots: E. Usami et al.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 2, p. 75, doi. 10.1007/s40267-025-01140-w

By:

Usami, Eiseki;
Moriya, Akihiro;
Jimichi, Taiga;
Asano, Hiroki;
Miyazaki, Masayuki;
Hirabatake, Masaki;
Muroi, Nobuyuki;
Tonogai, Yuki;
Hibi, Yoko;
Kimura, Michio

Publication type:

Article

Effect of Diabetes on Outcomes in Patients With Incurable/Unresectable and Advanced/Recurrent Colorectal Cancer Receiving mFOLFOX6.

Published in:

Cancer Diagnosis & Prognosis, 2025, v. 5, n. 1, p. 42, doi. 10.21873/cdp.10410

By:

MAI IKEMURA;
MASAKI HIRABATAKE;
MEGUMI ABURAYA;
HIROAKI IKESUE;
HISATERU YASUI;
NOBUYUKI MUROI;
TOHRU HASHIDA

Publication type:

Article

Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00389-z

By:

Futamura, Akihiko;
Koseki, Takenao;
Iida, Junichi;
Suzuki, Akito;
Muroi, Nobuyuki;
Myotoku, Michiaki;
Maki, Hiroki;
Mizutani, Kazuhisa;
Ogino, Hikaru;
Taniguchi, Yasuki;
Higashi, Keiichiro;
Usui, Masanobu

Publication type:

Article

Correction: Comparison of facilities with and without additional medical fees for nutrition support team activity during the COVID-19 pandemic.

Published in:

2025

By:

Futamura, Akihiko;
Koseki, Takenao;
Iida, Junichi;
Suzuki, Akito;
Muroi, Nobuyuki;
Myotoku, Michiaki;
Maki, Hiroki;
Mizutani, Kazuhisa;
Ogino, Hikaru;
Taniguchi, Yasuki;
Higashi, Keiichiro;
Usui, Masanobu

Publication type:

Correction Notice

Evaluating the safety and efficiency of robotic dispensing systems.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00255-w

By:

Takase, Tomoki;
Masumoto, Norio;
Shibatani, Naoki;
Matsuoka, Yusaku;
Tanaka, Fumiaki;
Hirabatake, Masaki;
Kashiwagi, Hiroko;
Nishioka, Itaru;
Ikesue, Hiroaki;
Hashida, Tohru;
Koide, Naoshi;
Muroi, Nobuyuki

Publication type:

Article

Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting.

Published in:

Journal of Pharmaceutical Health Care & Sciences, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s40780-021-00196-w

By:

Tanaka, Fumiaki;
Shibatani, Naoki;
Fujita, Kazumi;
Ikesue, Hiroaki;
Yoshimizu, Satoru;
Muroi, Nobuyuki;
Kurimoto, Yasuo;
Hashida, Tohru

Publication type:

Article

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 4, p. 513, doi. 10.1002/psp4.12936

By:

Tamura, Ryo;
Irie, Kei;
Nakagawa, Atsushi;
Muroi, Hirohito;
Eto, Masaaki;
Ikesue, Hiroaki;
Muroi, Nobuyuki;
Fukushima, Shoji;
Tomii, Keisuke;
Hashida, Tohru

Publication type:

Article

Population pharmacokinetics of favipiravir in patients with COVID‐19.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 10, p. 1161, doi. 10.1002/psp4.12685

By:

Irie, Kei;
Nakagawa, Atsushi;
Fujita, Hirotoshi;
Tamura, Ryo;
Eto, Masaaki;
Ikesue, Hiroaki;
Muroi, Nobuyuki;
Fukushima, Shoji;
Tomii, Keisuke;
Hashida, Tohru

Publication type:

Article

Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2021, v. 46, n. 1, p. 190, doi. 10.1111/jcpt.13279

By:

Yoshida, Saki;
Fujimoto, Ayumi;
Fukushima, Keizo;
Ando, Motozumi;
Irie, Kei;
Hirano, Tatsuya;
Miyasaka, Moena;
Shimomura, Yoshimitsu;
Ishikawa, Takayuki;
Ikesue, Hiroaki;
Muroi, Nobuyuki;
Hashida, Tohru;
Sugioka, Nobuyuki

Publication type:

Article

Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 6, p. 1288, doi. 10.1111/jcpt.13207

By:

Ikesue, Hiroaki;
Kusuda, Kaori;
Satsuma, Yukari;
Nishiwaki, Fuki;
Miura, Rieko;
Masuda, Yoshio;
Hirabatake, Masaki;
Muroi, Nobuyuki;
Fujimoto, Daichi;
Morimoto, Takeshi;
Tomii, Keisuke;
Hashida, Tohru

Publication type:

Article

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 2, p. 298, doi. 10.1111/jcpt.13065

By:

Takase, Tomoki;
Ikesue, Hiroaki;
Nakagawa, Haruna;
Kinoshita, Megumi;
Muroi, Nobuyuki;
Kitai, Takeshi;
Furukawa, Yutaka;
Hashida, Tohru

Publication type:

Article

Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.

Published in:

2021

By:

Yamashita, Kanae;
Shimomura, Yoshimitsu;
Ikesue, Hiroaki;
Muroi, Nobuyuki;
Yoshimoto, Akihiro;
Hashida, Tohru

Publication type:

journal article